| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Lung Cancer Branch, National Cancer Institute, NIH, Bethesda, Maryland 20014
The cause for the development of endophytic growth (nodular downgrowth) in rat urinary bladder epithelia cultured in protein-free medium was traced to a deficiency of Ca2+ in the culture medium. Endophytic growth, which is a characteristic in vivo histological feature of the preneoplastic phase of experimental bladder cancer, was induced in vitro by 0.3 mM Ca2+ but was suppressed by 1.8 mM Ca2+. Magnesium at 1.8 mM had no effect on endophytic growth.
Ca2+ deficiency was also found to be a significant cause of hyperplasia. Ca2+ concentrations above 0.9 mM resulted in a substantial inhibition of hyperplasia in the bladder epithelium; a greater than 50% inhibition was observed with 1.8 mM Ca2+. Conditions were found, however, which caused the suppression of endophytic growth without an apparent suppression of hyperplasia.
When the Ca2+ concentration was decreased to 0.075 mM and below, epithelial cells lost cohesiveness and infiltrated into the stroma. Epithelial cells were observed individually and in clusters within the lamina propria. Evidence of lytic activity was also observed in the lamina propria. Epithelial cells that infiltrated into the stroma displayed occasional mitotic figures and frequently contained abnormally appearing nucleoli.
The ability of low Ca2+ concentration in the culture medium to induce epithelia to mimic some of the growth patterns that appear during the development of experimental bladder cancer in vivo, suggests that there may be an early change in some aspect of cellular Ca2+ in epithelia and/or stroma that have been exposed to bladder carcinogens.
Received 7/25/77. Accepted 12/ 5/77.
This article has been cited by other articles:
![]() |
G. G. Long, V. L. Reynolds, A. Lopez-Martinez, T. E. Ryan, S. L. White, and S. R. Eldridge Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar, a {gamma}-dominant PPAR {alpha}/{gamma} Agonist: Lack of Evidence for Urolithiasis as an Inciting Event Toxicol Pathol, February 1, 2008; 36(2): 218 - 231. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Dominick, M. R. White, T. P. Sanderson, T. van Vleet, S. M. Cohen, L. E. Arnold, M. Cano, S. Tannehill-Gregg, J. D. Moehlenkamp, C. R. Waites, et al. Urothelial Carcinogenesis in the Urinary Bladder of Male Rats Treated with Muraglitazar, a PPAR{alpha}/{gamma} Agonist: Evidence for Urolithiasis as the Inciting Event in the Mode of Action Toxicol Pathol, December 1, 2006; 34(7): 903 - 920. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |